251 related articles for article (PubMed ID: 31711155)
1. Placental serotonin signaling, pregnancy outcomes, and regulation of fetal brain development†.
Rosenfeld CS
Biol Reprod; 2020 Mar; 102(3):532-538. PubMed ID: 31711155
[TBL] [Abstract][Full Text] [Related]
2. Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain.
Goeden N; Velasquez J; Arnold KA; Chan Y; Lund BT; Anderson GM; Bonnin A
J Neurosci; 2016 Jun; 36(22):6041-9. PubMed ID: 27251625
[TBL] [Abstract][Full Text] [Related]
3. Development of the Placenta and Brain Are Affected by Selective Serotonin Reuptake Inhibitor Exposure During Critical Periods.
Bravo K; González-Ortiz M; Beltrán-Castillo S; Cáceres D; Eugenín J
Adv Exp Med Biol; 2023; 1428():179-198. PubMed ID: 37466774
[TBL] [Abstract][Full Text] [Related]
4. Expression of placental serotonin transporter and 5-HT 2A receptor in normal and gestational diabetes mellitus pregnancies.
Viau M; Lafond J; Vaillancourt C
Reprod Biomed Online; 2009 Aug; 19(2):207-15. PubMed ID: 19712556
[TBL] [Abstract][Full Text] [Related]
5. Serotonin transporter protects the placental cells against apoptosis in caspase 3-independent pathway.
Hadden C; Fahmi T; Cooper A; Savenka AV; Lupashin VV; Roberts DJ; Maroteaux L; Hauguel-de Mouzon S; Kilic F
J Cell Physiol; 2017 Dec; 232(12):3520-3529. PubMed ID: 28109119
[TBL] [Abstract][Full Text] [Related]
6. Differential Serotonin Uptake Mechanisms at the Human Maternal-Fetal Interface.
Baković P; Kesić M; Perić M; Bečeheli I; Horvatiček M; George M; Čičin-Šain L; Desoye G; Wadsack C; Panzenboeck U; Štefulj J
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360573
[TBL] [Abstract][Full Text] [Related]
7. Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment.
Muller CL; Anacker AM; Rogers TD; Goeden N; Keller EH; Forsberg CG; Kerr TM; Wender C; Anderson GM; Stanwood GD; Blakely RD; Bonnin A; Veenstra-VanderWeele J
Neuropsychopharmacology; 2017 Jan; 42(2):427-436. PubMed ID: 27550733
[TBL] [Abstract][Full Text] [Related]
8. Fetal, maternal, and placental sources of serotonin and new implications for developmental programming of the brain.
Bonnin A; Levitt P
Neuroscience; 2011 Dec; 197():1-7. PubMed ID: 22001683
[TBL] [Abstract][Full Text] [Related]
9. Placental Changes in the serotonin transporter (Slc6a4) knockout mouse suggest a role for serotonin in controlling nutrient acquisition.
Mao J; Kinkade JA; Bivens NJ; Roberts RM; Rosenfeld CS
Placenta; 2021 Nov; 115():158-168. PubMed ID: 34649169
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine and its active metabolite norfluoxetine disrupt estrogen synthesis in a co-culture model of the feto-placental unit.
Hudon Thibeault AA; Laurent L; Vo Duy S; Sauvé S; Caron P; Guillemette C; Sanderson JT; Vaillancourt C
Mol Cell Endocrinol; 2017 Feb; 442():32-39. PubMed ID: 27890559
[TBL] [Abstract][Full Text] [Related]
11. Serotonin Transporter-dependent Histone Serotonylation in Placenta Contributes to the Neurodevelopmental Transcriptome.
Chan JC; Alenina N; Cunningham AM; Ramakrishnan A; Shen L; Bader M; Maze I
J Mol Biol; 2024 Apr; 436(7):168454. PubMed ID: 38266980
[TBL] [Abstract][Full Text] [Related]
12. Differential patterning of genes involved in serotonin metabolism and transport in extra-embryonic tissues of the mouse.
Wu HH; Choi S; Levitt P
Placenta; 2016 Jun; 42():74-83. PubMed ID: 27238716
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a human placental clearance system to regulate serotonin levels in the fetoplacental unit.
Staud F; Pan X; Karahoda R; Dong X; Kastner P; Horackova H; Vachalova V; Markert UR; Abad C
Reprod Biol Endocrinol; 2023 Aug; 21(1):74. PubMed ID: 37612712
[TBL] [Abstract][Full Text] [Related]
14. Pathway of Maternal Serotonin to the Human Embryo and Fetus.
Kliman HJ; Quaratella SB; Setaro AC; Siegman EC; Subha ZT; Tal R; Milano KM; Steck TL
Endocrinology; 2018 Apr; 159(4):1609-1629. PubMed ID: 29381782
[TBL] [Abstract][Full Text] [Related]
15. A transient placental source of serotonin for the fetal forebrain.
Bonnin A; Goeden N; Chen K; Wilson ML; King J; Shih JC; Blakely RD; Deneris ES; Levitt P
Nature; 2011 Apr; 472(7343):347-50. PubMed ID: 21512572
[TBL] [Abstract][Full Text] [Related]
16. Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation†.
Domingues RR; Wiltbank MC; Hernandez LL
Biol Reprod; 2023 Jul; 109(1):17-28. PubMed ID: 37098165
[TBL] [Abstract][Full Text] [Related]
17. The expression and activity of monoamine oxidase A, but not of the serotonin transporter, is decreased in human placenta from pre-eclamptic pregnancies.
Carrasco G; Cruz MA; Dominguez A; Gallardo V; Miguel P; González C
Life Sci; 2000 Nov; 67(24):2961-9. PubMed ID: 11133008
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of mechanistic target of rapamycin signaling decreases levels of O-GlcNAc transferase and increases serotonin release in the human placenta.
Kelly AC; Kramer A; Rosario FJ; Powell TL; Jansson T
Clin Sci (Lond); 2020 Dec; 134(23):3123-3136. PubMed ID: 33215629
[TBL] [Abstract][Full Text] [Related]
19. In utero exposure to venlafaxine, a serotonin-norepinephrine reuptake inhibitor, increases cardiac anomalies and alters placental and heart serotonin signaling in the rat.
Laurent L; Huang C; Ernest SR; Berard A; Vaillancourt C; Hales BF
Birth Defects Res A Clin Mol Teratol; 2016 Dec; 106(12):1044-1055. PubMed ID: 27384265
[TBL] [Abstract][Full Text] [Related]
20. Effects of prenatal opioid and alcohol exposures on immune and serotonin factors in human placenta.
Ruyak SL; Noor S; DiDomenico J; Sun MS; Fernandez Oropeza AK; Rodriguez DE; Marquez LE; Milligan ED; Bakhireva LN
Exp Neurol; 2022 Jul; 353():114057. PubMed ID: 35364108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
